GlassScriptPhysician profile
Kyra Gabow
NPI 1124642285
$1,091.02
in general payments reported to CMS, 2019-2025
10 companies · $254 in 2025
The $254 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $360 · 2022: $206 · 2023: $201 · 2024: $70.97 · 2025: $254.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $525.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $525.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nevro Corp. | $231.91 | 2022-2023 | Senza |
| Stryker Corporation | $216.91 | 2021 | |
| Mml US, INC. | $146.35 | 2025 | Reactiv8 |
| Orthofix Medical, INC. | $134.60 | 2021-2025 | Cervical-Stim, Spinal-Stim |
| Alnylam Pharmaceuticals INC. | $123.61 | 2023 | Amvuttra |
| Life Spine, INC. | $112.17 | 2021 | |
| Si-Bone, INC. | $39.63 | 2024 | |
| Spinal Simplicity, LLC | $31.34 | 2024 | Ha Minuteman G3-R |
| Ethicon US, LLC | $29.63 | 2025 | Vistaseal, Dermabond Prineo, Ethicon |
| Globus Medical, INC. | $24.87 | 2025 | Vyrsa V1 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kyra Gabow listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.